| HERON THERAPEUTICS DL-,01 |
| USA |
| Gesundheit |
| US4277461020 / A1XB6K |
| AXD2 (Frankfurt) / HRTX (NASDAQ) |
| FRA:AXD2, ETR:AXD2, AXD2:GR, NASDAQ:HRTX |
| - |
| https://www.herontx.com/ |
|
Heron Therapeutics Inc. is a biotechnology company dedicated to the development and commercialization of therapeutic treatments to address unmet medical needs. The company's primary focus is on improving the lives of patients suffering from cancer an..
>Volltext.. |
| 131.24 Mio. EUR |
| 212.13 Mio. EUR |
| 134.2 Mio. EUR |
| 0.24 Mio. EUR |
| -17.5 Mio. EUR |
| -0.1 EUR |
| 121.84 Mio. EUR |
| 24.82 Mio. EUR |
| -23.9 Mio. EUR |
| 0.49 |
| -5.37% |
| -31.08% |
| - |
| - |
| - |
| - |
| HERON THERAPEUTICS, HERON THERAPEUTIC |
| 05.04.26 |
|
||||
|
||||
|
||||
|